Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, Staudingerweg 5, D-55128 Mainz, Germany.
TU Dortmund University, Chemical Biology, Otto-Hahn-Str. 6, D-44227 Dortmund, Germany.
ACS Chem Biol. 2021 Apr 16;16(4):661-670. doi: 10.1021/acschembio.0c00911. Epub 2021 Mar 15.
Viral and parasitic pathogens rely critically on cysteine proteases for host invasion, replication, and infectivity. Their inhibition by synthetic inhibitors, such as vinyl sulfone compounds, has emerged as a promising treatment strategy. However, the individual reaction steps of protease inhibition are not fully understood. Using the trypanosomal cysteine protease rhodesain as a medically relevant target, we design photoinduced electron transfer (PET) fluorescence probes to detect kinetics of binding of reversible and irreversible vinyl sulfones directly in solution. Intriguingly, the irreversible inhibitor, apart from its unlimited residence time in the enzyme, reacts 5 times faster than the reversible one. Results show that the reactivity of the warhead, and not binding of the peptidic recognition unit, limits the rate constant of protease inhibition. The use of a reversible inhibitor decreases the risk of off-target side effects not only by allowing its release from an off-target but also by reducing the rate constant of binding.
病毒和寄生虫病原体严重依赖半胱氨酸蛋白酶来入侵宿主、复制和感染。它们被合成抑制剂(如乙烯砜化合物)抑制,已成为一种有前途的治疗策略。然而,蛋白酶抑制的各个反应步骤尚未完全理解。我们以原生动物半胱氨酸蛋白酶 rhodesain 为医学相关靶点,设计光诱导电子转移(PET)荧光探针,直接在溶液中检测可逆和不可逆乙烯砜结合的动力学。有趣的是,不可逆抑制剂除了在酶中的停留时间不受限制外,其反应速度比可逆抑制剂快 5 倍。结果表明,反应基团的反应性,而不是肽识别单元的结合,限制了蛋白酶抑制的速率常数。使用可逆抑制剂不仅通过允许其从非靶标释放,而且通过降低结合速率常数,降低了非靶标副作用的风险。